Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 4/20 | 0.59 |
| ▸ | INPP5A | Q14642 | 3/20 | 0.59 |
| ▸ | TTR | P02766 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | SRC | P12931 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 4/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.48 |
| ▸ | NQO2 | P16083 | 3/20 | 0.48 |
| ▸ | ABL1 | P00519 | 2/20 | 0.48 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4736118 | 0.90 | CYP1A1 (0.66) | TTRKDM4EMEN1MAPTKMT2A | |
| SCHEMBL4734848 | 0.90 | CYP1A1 (0.66) | TTRKDM4EMEN1MAPTKMT2A | |
| SCHEMBL12205333 | 0.88 | INPPL1 (0.46) | INPPL1INPP5ATTRKDM4ESRC | |
| SCHEMBL30340032 | 0.87 | PTGS1 (0.58) | INPPL1INPP5ATTRKDM4ESRC | |
| SCHEMBL2193074 | 0.84 | PTGS2 (0.60) | INPPL1INPP5ATTRKDM4ESRC | |
| SCHEMBL30340348 | 0.84 | PTGS2 (0.60) | INPPL1INPP5ATTRKDM4ESRC | |
| SCHEMBL6951492 | 0.83 | KDM4E (0.50) | INPPL1INPP5ATTRKDM4ESRC | |
| SCHEMBL9019350 | 0.83 | SRC (0.67) | INPPL1INPP5ASRCKMT2ACA1 | |
| SCHEMBL4166639 | 0.83 | PTGS2 (0.58) | INPPL1INPP5ATTRKDM4ESRC | |
| SCHEMBL4261552 | 0.82 | PTGS2 (0.64) | INPPL1INPP5AMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250017835-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND RESVERATROL AND/OR A RESVERATROL DERIVATIVE | L'OREAL (FR) | 2025-01-16 | — | — | US | claimed |
| CN-118742282-A | Cosmetic or dermatological composition comprising a merocyanine and resveratrol and/or resveratrol derivative | 莱雅公司 | 2024-10-01 | — | — | CN | claimed |
| WO-2023110764-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND RESVERATROL AND/OR A RESVERATROL DERIVATIVE | L'OREAL (FR) | 2023-06-22 | — | — | WO | claimed |
| US-9782448-B2 | Methods and compositions for treating skin | ELC MANAGEMENT LLC (US) | 2017-10-10 | — | — | US | claimed |
| EP-3104836-A1 | METHOD, COMPOSITIONS, AND KIT FOR MODULATING THE APPEARANCE OF VOLUME ON KERATIN SURFACES | ELC Management LLC (US) | 2016-12-21 | — | — | EP | claimed |
| US-20160354303-A1 | Method, Compositions, And Kit For Modulating The Appearance Of Volume On Keratin Surfaces | ELC MAN LLC (US) | 2016-12-08 | — | — | US | claimed |
| WO-2015123115-A1 | METHOD, COMPOSITIONS, AND KIT FOR MODULATING THE APPEARANCE OF VOLUME ON KERATIN SURFACES | ELC MANAGEMENT LLC (US) | 2015-08-20 | — | — | WO | claimed |
| US-20140161898-A1 | Methods and Compositions for Treating Skin | ELC MANAGEMENT, LLC (US) | 2014-06-12 | — | — | US | claimed |
| US-8535738-B2 | Methods and compositions for treating skin | ELC MANAGEMENT, LLC (US) | 2013-09-17 | — | — | US | claimed |
| US-8465973-B2 | Topical compositions containing phosphorylated polyphenols | ESTEE LAUDER COORDINATION CENTER N.V. (BE) | 2013-06-18 | — | — | US | claimed |
| EP-2429481-A2 | METHOD AND COMPOSITIONS FOR IMPROVING SKIN AND BODY APPEARANCE | ELC Management LLC (US) | 2012-03-21 | — | — | EP | claimed |
| US-20110268688-A1 | METHOD AND COMPOSITIONS FOR IMPROVING SKIN AND BODY APPEARANCE | ELC MANAGEMENT LLC | 2011-11-03 | — | — | US | claimed |
| WO-2010146142-A9 | METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES | HDS LIMITED (GB) | 2011-06-16 | — | — | WO | claimed |
| WO-2009158248-A2 | METHOD AND COMPOSITIONS FOR IMPROVING SKIN AND BODY APPEARANCE | ELC MANAGEMENT LLC (US) | 2009-12-30 | — | — | WO | claimed |
| US-20090247490-A1 | Topical Compositions Containing Phosphorylated Polyphenols | DECLERCQ LIEVE | 2009-10-01 | — | — | US | claimed |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | claimed |
| US-20250017835-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND RESVERATROL AND/OR A RESVERATROL DERIVATIVE | L'OREAL (FR) | 2025-01-16 | — | — | US | disclosed |
| EP-4291301-B1 | NON-INVASIVE CANCER TREATMENT | SCIENTIA BIOTECH S L (ES) | 2025-01-15 | — | — | EP | disclosed |
| WO-2006029484-A1 | TOPICAL COMPOSITIONS CONTAINING PHOSPHORYLATED POLYPHENOLS | AJINOMOTO OMNICHEM S.A. (BE) | 2006-03-23 | — | — | WO | disclosed |
| WO-2006029483-A1 | PHOSPHORYLATED POLYPHENOLS AS COLOUR-STABLE AGENTS | AJINOMOTO OMNICHEM S.A. (BE) | 2006-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247490-A1 | Topical Compositions Containing Phosphorylated Polyphenols | PPP5C, CHAMP1, PLK1 | INPPL1 146/4885INPP5A 327/4885TTR 1134/4885 |
| US-20250017835-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND RESVERATROL AND/OR A RESVERATROL DERIVATIVE | KRT18, ECH1, VIM | INPPL1 4217/4885INPP5A 4573/4885TTR 1983/4885 |
| US-20160354303-A1 | Method, Compositions, And Kit For Modulating The Appearance Of Volume On Keratin Surfaces | KRT18, KIT, KLKB1 | INPPL1 3292/4885INPP5A 4492/4885TTR 1506/4885 |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | CUTA, LRAT, RARA | INPPL1 1686/4885INPP5A 2663/4885TTR 1922/4885 |
| US-20140161898-A1 | Methods and Compositions for Treating Skin | LTB4R2, LTB4R, CYSLTR2 | INPPL1 1296/4885INPP5A 3408/4885TTR 4817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.